ProMIS Neurosciences is trading 11.1% down at $9.64, with no specific catalyst identified for the October 1, 2026 decline. - Its latest release, dated September 30, announced participation in October conferences. - Treasury yields reportedly surged, but supplied major-index moves were modest and do not establish a macro cause for the drop.